GLYC logo

GlycoMimetics (GLYC) Current Liabilities

Annual Current Liabilities

$6.84 M
-$2.05 M-23.03%

December 31, 2023


Summary


Performance

GLYC Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLYCbalance sheetmetrics:

Quarterly Current Liabilities

$4.32 M
-$34.40 K-0.79%

September 30, 2024


Summary


Performance

GLYC Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGLYCbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

GLYC Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.0%-36.8%
3 y3 years-45.0%-63.5%
5 y5 years-22.0%-63.5%

GLYC Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-42.2%at low-66.2%at low
5 y5-year-45.0%at low-66.2%at low
alltimeall time-58.4%+199.9%-66.2%+159.4%

GlycoMimetics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$4.32 M(-0.8%)
Jun 2024
-
$4.36 M(-17.7%)
Mar 2024
-
$5.29 M(-22.5%)
Dec 2023
$6.84 M(-23.0%)
$6.84 M(+7.0%)
Sep 2023
-
$6.39 M(-2.8%)
Jun 2023
-
$6.57 M(-2.5%)
Mar 2023
-
$6.74 M(-24.1%)
Dec 2022
$8.88 M(-24.9%)
$8.88 M(+14.6%)
Sep 2022
-
$7.75 M(-13.3%)
Jun 2022
-
$8.94 M(-30.1%)
Mar 2022
-
$12.78 M(+8.1%)
Dec 2021
$11.82 M(-4.9%)
$11.82 M(+22.4%)
Sep 2021
-
$9.66 M(-5.7%)
Jun 2021
-
$10.25 M(-5.5%)
Mar 2021
-
$10.84 M(-12.8%)
Dec 2020
$12.43 M(+13.5%)
$12.43 M(+26.6%)
Sep 2020
-
$9.82 M(+1.2%)
Jun 2020
-
$9.70 M(-8.6%)
Mar 2020
-
$10.61 M(-3.1%)
Dec 2019
$10.95 M(+25.0%)
$10.95 M(+4.9%)
Sep 2019
-
$10.44 M(-1.8%)
Jun 2019
-
$10.63 M(+28.0%)
Mar 2019
-
$8.31 M(-5.2%)
Dec 2018
$8.76 M
$8.76 M(+36.2%)
DateAnnualQuarterly
Sep 2018
-
$6.43 M(-8.6%)
Jun 2018
-
$7.04 M(-19.1%)
Mar 2018
-
$8.70 M(+6.4%)
Dec 2017
$8.17 M(+29.1%)
$8.17 M(+25.2%)
Sep 2017
-
$6.53 M(+19.9%)
Jun 2017
-
$5.45 M(+20.1%)
Mar 2017
-
$4.53 M(-28.4%)
Dec 2016
$6.33 M(-18.2%)
$6.33 M(+16.9%)
Sep 2016
-
$5.42 M(-11.1%)
Jun 2016
-
$6.09 M(+7.2%)
Mar 2016
-
$5.68 M(-26.6%)
Dec 2015
$7.75 M(+19.9%)
$7.75 M(+13.1%)
Sep 2015
-
$6.85 M(+0.8%)
Jun 2015
-
$6.80 M(+65.6%)
Mar 2015
-
$4.10 M(-36.5%)
Dec 2014
$6.46 M(+183.4%)
$6.46 M(+37.1%)
Sep 2014
-
$4.71 M(+31.0%)
Jun 2014
-
$3.60 M(+36.1%)
Mar 2014
-
$2.64 M(+15.9%)
Dec 2013
$2.28 M(-60.0%)
$2.28 M(-22.0%)
Sep 2013
-
$2.92 M(+75.4%)
Jun 2013
-
$1.67 M(-70.7%)
Dec 2012
$5.69 M(-65.3%)
$5.69 M
Dec 2011
$16.41 M
-

FAQ

  • What is GlycoMimetics annual total current liabilities?
  • What is the all time high annual current liabilities for GlycoMimetics?
  • What is GlycoMimetics annual current liabilities year-on-year change?
  • What is GlycoMimetics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for GlycoMimetics?
  • What is GlycoMimetics quarterly current liabilities year-on-year change?

What is GlycoMimetics annual total current liabilities?

The current annual current liabilities of GLYC is $6.84 M

What is the all time high annual current liabilities for GlycoMimetics?

GlycoMimetics all-time high annual total current liabilities is $16.41 M

What is GlycoMimetics annual current liabilities year-on-year change?

Over the past year, GLYC annual total current liabilities has changed by -$2.05 M (-23.03%)

What is GlycoMimetics quarterly total current liabilities?

The current quarterly current liabilities of GLYC is $4.32 M

What is the all time high quarterly current liabilities for GlycoMimetics?

GlycoMimetics all-time high quarterly total current liabilities is $12.78 M

What is GlycoMimetics quarterly current liabilities year-on-year change?

Over the past year, GLYC quarterly total current liabilities has changed by -$2.51 M (-36.77%)